Denise P. Carter insider trades: Quoin Pharmaceuticals (QNRX) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Denise reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | QNRX | ↑ Buy | 20,490 | $4.88 | $100K | Direct | Sep 1, 2026 (1d) |
| Dec 23, 2024 | QNRX | ↑ Buy | 555,556 | $0.45 | $250K | Direct | Dec 27, 2024 (4d) |
| Sep 4, 2024 | QNRX | ↑ Buy | 37,735 | $0.76 | $29K | Direct | Sep 5, 2024 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other QNRX insiders
Open-market trades in the last 12 months
About Denise P. Carter's insider trades
Denise P. Carter is Chief Operating Officer at Quoin Pharmaceuticals (QNRX). Since Sep 4, 2024, Denise has reported 3 open-market purchases worth $379K and no sales on SEC Form 4. In the last 12 months: 1 buy ($100K).
Their filings also include grants and awards (4 filings), other transactions (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every QNRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.